Chris Rallis - Dec 26, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Stock symbol
FENC
Transactions as of
Dec 26, 2023
Transactions value $
-$15,151
Form type
4
Date filed
12/28/2023, 04:02 PM
Previous filing
Nov 20, 2023
Next filing
Mar 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale -$15.2K -1.39K -3.01% $10.90 44.8K Dec 26, 2023 Direct F1
transaction FENC Common Shares Options Exercise $5K +3.14K +7.31% $1.59* 46.2K Dec 26, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Common Shares Options Exercise -$5K -3.14K -1.68% $1.59* 184K Dec 26, 2023 Options 3.14K $1.59 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligation on option exercise.
F2 Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024.
F3 Represents options granted on January 24, 2014, with a strike price of $1.59 and expiration date of January 24, 2024.